68
Views
16
CrossRef citations to date
0
Altmetric
Review

Survivin-T34A: molecular mechanism and therapeutic potential

&
Pages 247-254 | Published online: 06 Dec 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Rosemol George, Stephanie Hehlgans, Maximillian Fleischmann, Claus Rödel, Emmanouil Fokas & Franz Rödel. (2022) Advances in nanotechnology-based platforms for survivin-targeted drug discovery. Expert Opinion on Drug Discovery 17:7, pages 733-754.
Read now
Hosna Gomari, Mehdi Forouzandeh Moghadam & Masoud Soleimani. (2018) Targeted cancer therapy using engineered exosome as a natural drug delivery vehicle. OncoTargets and Therapy 11, pages 5753-5762.
Read now
Li Luo, Ting Du, Jiumeng Zhang, Wei Zhao, Hao Cheng, Yuping Yang, Yujiao Wu, Chunmei Wang, Ke Men & Maling Gou. (2016) Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene. International Journal of Nanomedicine 11, pages 501-513.
Read now

Articles from other publishers (13)

Divya Ramesh, Shankar Bakkannavar, Vinutha R Bhat & Krishna Sharan. (2023) Extracellular vesicles as novel drug delivery systems to target cancer and other diseases: Recent advancements and future perspectives. F1000Research 12, pages 329.
Crossref
Anjali Pandya, Sreeranjini Pulakkat & Vandana Patravale. 2022. Targeted Drug Delivery. Targeted Drug Delivery 193 220 .
Ga Yeong Yi, Min Ju Kim, Hyo In Kim, Jinbong Park & Seung Ho Baek. (2022) Hyperthermia Treatment as a Promising Anti-Cancer Strategy: Therapeutic Targets, Perspective Mechanisms and Synergistic Combinations in Experimental Approaches. Antioxidants 11:4, pages 625.
Crossref
Jingwen Jiang, Jiayu Li, Xiumei Zhou, Xueqin Zhao, Biao Huang & Yuan Qin. (2022) Exosomes Regulate the Epithelial–Mesenchymal Transition in Cancer. Frontiers in Oncology 12.
Crossref
Robert C. Mould, Jacob P. van Vloten, Amanda W. K. AuYeung, Scott R. Walsh, Jondavid de Jong, Leonardo Susta, Anthony J. Mutsaers, James J. Petrik, Geoffrey A. Wood, Sarah K. Wootton, Khalil Karimi & Byram W. Bridle. (2021) Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of Survivin. Cancers 13:24, pages 6270.
Crossref
Ameneh Jafari, Amirhesam Babajani, Meghdad Abdollahpour-Alitappeh, Nayebali Ahmadi & Mostafa Rezaei-Tavirani. (2021) Exosomes and cancer: from molecular mechanisms to clinical applications. Medical Oncology 38:4.
Crossref
Isha Gaurav, Abhimanyu Thakur, Ashok Iyaswamy, Xuehan Wang, Xiaoyu Chen & Zhijun Yang. (2021) Factors Affecting Extracellular Vesicles Based Drug Delivery Systems. Molecules 26:6, pages 1544.
Crossref
Narasimha M. Beeraka, Shalini H. Doreswamy, Surya P. Sadhu, Asha Srinivasan, Rajeswara Rao Pragada, SubbaRao V. Madhunapantula & Gjumrakch Aliev. (2020) The Role of Exosomes in Stemness and Neurodegenerative Diseases—Chemoresistant-Cancer Therapeutics and Phytochemicals. International Journal of Molecular Sciences 21:18, pages 6818.
Crossref
Fabiao Hu, Daxia Pan, Wenyun Zheng, Ting Yan, Xiujuan He, Fuzheng Ren, Yiming Lu & Xingyuan Ma. (2017) Elucidating respective functions of two domains BIR and C-helix of human IAP survivin for precise targeted regulating mitotic cycle, apoptosis and autophagy of cancer cells. Oncotarget 8:69, pages 113687-113700.
Crossref
Mohadeseh Hasanpourghadi, Ashok Kumar Pandurangan, Chandrabose Karthikeyan, Piyush Trivedi & Mohd Rais Mustafa. (2017) Mechanisms of the anti-tumor activity of Methyl 2-(-5-fluoro-2-hydroxyphenyl)-1 H-benzo[d]imidazole-5-carboxylate against breast cancer in vitro and in vivo . Oncotarget 8:17, pages 28840-28853.
Crossref
Jinheng Wang, Yongjiang Zheng & Meng Zhao. (2017) Exosome-Based Cancer Therapy: Implication for Targeting Cancer Stem Cells. Frontiers in Pharmacology 7.
Crossref
Ferry Sandra & Roya Khosravi-Far. (2011) Phosphorylated-Survivin at Ser81 Induced Protein Kinase A (PKA): A Back Loop. The Indonesian Biomedical Journal 3:2, pages 138.
Crossref
Ferry Sandra & Roya Khosravi-Far. (2010) Survivin S81A Enhanced TRAIL's Activity in Inducing Apoptosis. The Indonesian Biomedical Journal 2:3, pages 113.
Crossref